C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 513/04 (2006.01) A61K 31/429 (2006.01)
Patent
CA 2597288
Compounds of formula (I) or pharmaceutically acceptable salts thereof, exhibit 5-HT1A agonism in addition to noradrenaline reuptake inhibition and optionally also 5-HT reuptake inhibition are useful for the treatment of obesity.
L'invention concerne des composés de la formule (I), ou des sels pharmaceutiquement acceptables de ceux-ci, qui présentent un agonisme 5-HT1A, outre l'inhibition de la recapture de la noradrénaline et éventuellement l'inhibition de la recapture de 5-HT, et qui sont utilisés dans le traitement de l'obésité.
Barba Oscar
Dawson Graham John
Krulle Thomas Martin
Rowley Robert John
Smyth Donald
Macrae & Co.
Prosidion Limited
LandOfFree
Dihydroimidazothiazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydroimidazothiazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydroimidazothiazole derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1812588